WASHINGTON &#x 2014; A prominent Senate Democrat is pressing back versus his celebration &#x 2019; s efforts to cut $600 billion out of the drug market as part of an enormous yet-to-be-unveiled costs bundle.
Because July, it &#x 2019; s been commonly reported that Democrats are seeking around $600 billion in cost savings from the pharmaceutical market to assist spend for a variety of policy top priorities. However Sen. Tom Carper (D-Del.) informed STAT in an interview Tuesday that he thought the objective of cutting $600 billion out of the drug market was too enthusiastic.
Continue to STAT+ to check out the complete story & hellip;